+
Site Tour

Premiclose 2022: Evaluating midterm evolution of PDA closure. How can we improve?

In two separate talks, Evan Zahn discusses the fate of the left pulmonary artery and thoracic aorta after transcatheter PDA closure in preterm infants <2 kg, and Jean Christophe Roze speaks about medium term clinical follow-up after percutaneous closure and evolution of the neurological and respiratory systems.

Related Videos

Premiclose 2022: Transcatheter PDA closure

Premiclose 2022: After 10 years

Premiclose 2022: Pre-term PDA

Premiclose 2022: Complications in PDA closure

LAAO Summit 2023: Anatomy & imaging – The future

Review the Trends | Mitral focus

Left Atrial Appendage Occlusion (LAAO)

LAAO Summit 2022: Live case: Denmark

LAAO Summit - LAAO in a patient at risk of DRT

PremiClose 2024: Pediatric cardiologist view

LAAO Summit - Debate: Factor XI inhibitors

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

Amplatzer™ Septal Occluder (ASO) technical brochure

ESOC presentation: PFO closure in patients > 60 Years

Clinical trial summary: Piccolo™

Clinical insights: Intaglio™

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit 2023: Minimal anti-thrombotic therapy

MitraClip - AVVS 1 year 1 minute Mitral - Video

LAAO Summit - LAAO with risk of leak

LAAO Summit - The right antithrombotic regimen

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline